- Home
- ICON vs CNSP Comparison
ICON vs CNSP Comparison
Compare ICON & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- CNSP
- Stock Information
- Founded
- ICON 2023
- CNSP 2017
- Country
- ICON Greece
- CNSP United States
- Employees
- ICON N/A
- CNSP N/A
- Industry
- ICON
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- ICON
- CNSP Health Care
- Exchange
- ICON Nasdaq
- CNSP Nasdaq
- Market Cap
- ICON 5.2M
- CNSP 5.6M
- IPO Year
- ICON 2024
- CNSP 2019
- Fundamental
- Price
- ICON $2.37
- CNSP $7.57
- Analyst Decision
- ICON Strong Buy
- CNSP Hold
- Analyst Count
- ICON 1
- CNSP 1
- Target Price
- ICON $4.50
- CNSP N/A
- AVG Volume (30 Days)
- ICON 206.5K
- CNSP 30.2K
- Earning Date
- ICON 09-09-2025
- CNSP 08-13-2025
- Dividend Yield
- ICON 396.62%
- CNSP N/A
- EPS Growth
- ICON N/A
- CNSP N/A
- EPS
- ICON N/A
- CNSP N/A
- Revenue
- ICON $6,137,000.00
- CNSP N/A
- Revenue This Year
- ICON $51.78
- CNSP N/A
- Revenue Next Year
- ICON $51.90
- CNSP N/A
- P/E Ratio
- ICON N/A
- CNSP N/A
- Revenue Growth
- ICON 16.93
- CNSP N/A
- 52 Week Low
- ICON $1.60
- CNSP $7.45
- 52 Week High
- ICON $130.80
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- ICON N/A
- CNSP 35.80
- Support Level
- ICON N/A
- CNSP $7.50
- Resistance Level
- ICON N/A
- CNSP $8.33
- Average True Range (ATR)
- ICON 0.00
- CNSP 0.88
- MACD
- ICON 0.00
- CNSP -0.09
- Stochastic Oscillator
- ICON 0.00
- CNSP 11.34
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.